Lars Molin
Karolinska University Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Lars Molin.
Chemotherapy | 1971
Anna-Stina Malmborg; Lars Molin; Bertil Nyström
Uncomplicated acute gonorrhea in 200 cases, 100 of each sex, was treated with a single oral dose of 900 mg rifampicin. The failure rate was 12.5%. The treatment was compared with 1.0 MU of benzyl peni
Chemotherapy | 1973
Anna-Stina Malmborg; Lars Molin; Bertil Nyström
In the treatment of uncomplicated gonorrhoea pivampicillin, a recently introduced ampicillin derivative with improved oral absorption, has been compared with oral ampicillin and parenteral penicillin
Chemotherapy | 1970
Lars Molin; Bertil Nyström
Uncomplicated acute gonorrhoea in 200 cases, 100 of each sex, was treated with a single intra-muscular injection of 2 g of cephaloridine. The failure rate was 10.5 %. This treatment was compared with
Scandinavian journal of social medicine | 1973
Lars Molin
Socio-medical circumstances have been studied in previously hospitalized psoriatics living in a metropolitan area. The patterns seen in male and female psoriatics differed. The males were less often gainfully employed, belonged to a lower social class, and had lower incomes than their contrasts. The differences were mostly small, however. The females, on the other hand, were more often gainfully employed, belonged to a higher social class, and had higher incomes than their contrasts. The differences were relatively large and were of statistical significance. In the material studied there was also a marked difference according to sex as regards the severity of psoriasis. The severity of the course of the disease was more severe in the males than in the females. The subjective complaints, however, were assessed almost equal in males and females. The social variables studied could not be convincingly related to the severity of psoriasis or to the subjective assessment of complaints due to the skin disease. Factors other than psoriasis per se were considered more significant, such as primarily varying ability amongst psoriatics to utilize the available medical facilities. Apart from psoriasis itself, the greater morbidity in the psoriatics as compared with their contrasts indicated that psoriatics were more likely to seek hospital treatment for psoriasis if they also had other diseases.
Mycoses | 2009
Lars Molin
In 20 males with superficial dermatophytic infections 15 were given griseofulvin during 6 months (1 gram pro die) and 5, as controls, only topical treatment. Delayed hypersensitivity was investigated by means of tuberculin (old tuberkulin) and trichophytin tests before and during the treatment. No reduction of the reactions were noted, thus indicating that the suppressive effect of griseofulvin is weak and seems to be negligible at least during treatment periods not exceeding half a year.
Archives of Dermatology | 1976
Gerd Michaëlsson; Lars Molin; Sven Öhman; Lennart Gip; Börje Lindström; Marcus Skogh; Ingrid Trolin
Mycoses | 2009
Lennart Gip; Lars Molin
Archives of Dermatology | 1982
Gunnar Volden; Lars Molin; Kristian Thomsen
Chemotherapy | 1971
Meir Kende; J. P. Glynn; D.M. Goldenberg; R.L. Lipman; R.H. McDonald; R.H. Connamacher; A.P. Sharpio; C. Prakash; B.C. Bansal; R.R. Gupta; G. Giunchi; F. de Rosa; F. Fabiani; Anna-Stina Malmborg; Lars Molin; Bertil Nyström; R.C. Misra; D.D. Kulpati; Saroj Bala; K. Prakash; S.K. Gupta; H.K. Chuttani
Chemotherapy | 1970
D.E. Schwartz; J. Rieder; F. Cambieri; A. Gambini; E. Lodola; J.T. Smith; J.M.T. Hamilton-Miller; E. Yourassowsky; R. Monsieur; Lars Molin; Bertil Nyström